Seed · Biotech · Paris, France · Founded 2022 · 11–50 employees
Amatera Biosciences is an agricultural biotechnology company developing CellTera, a non-GMO plant breeding platform that combines cell culture, automation, and machine learning. The technology shifts the breeding and screening bottleneck from physical fields to the cellular level, accelerating the evolution of perennial crops up to two times faster than traditional methods. The startup is actively developing climate-resilient coffee hybrids, naturally decaffeinated coffee beans, and mildew-resistant Merlot grapevines. Amatera secured a six million euro seed round in March 2026 to scale its operations. Additionally, the company was selected for the European Innovation Council Accelerator program in June 2026, securing blended finance support.
No open roles listed right now.